The Food and Drug Administration’s updated final guidance on breakthrough devices seeks to clarify components of the program related to reducing inequities in healthcare.
The updated document, dated 15 September, supersedes draft guidance the agency issued in October 2022, “Select Updates for the Breakthrough Devices
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?